Story
Norwegian Stocks Close Lower as Energy Shares Fall with Oil Prices
Summary
The Oslo Børs benchmark index fell 0.54% on Monday, dragged down by significant losses in major energy stocks like Equinor as global crude oil prices saw a sharp decline.
Norwegian equities closed in negative territory on Monday, with the benchmark index pulled lower by a sharp downturn in energy sector stocks as global oil prices tumbled.
The Oslo OSE Total Return Index finished the session down 0.54%. The decline was broad-based, with the Media, Transportation, and Diversified Financials sectors leading the losses, according to data from Investing.com.
Key Movers and Market Breadth
Market sentiment was broadly negative, with 144 stocks declining compared to 111 advancers on the Oslo Stock Exchange, while 31 ended the session unchanged. The energy and seafood sectors saw some of the most significant losses.
- Salmar ASA (OL:SALM), a major salmon producer, was the weakest performer on the index, falling 3.64% to close at 530.00.
- Energy giant Equinor ASA (OL:EQNR) dropped 3.44% to 404.60.
- Var Energi ASA (OL:VAR) also declined, losing 3.16% to finish at 52.10.
AdBucking the downward trend were a few notable gainers, including Nordic Semiconductor ASA (OL:NOD) and Orkla ASA (OL:ORK), both of which rose 2.54%.
Commodity and Currency Impact
The sell-off in Norwegian energy stocks coincided with a significant drop in crude oil prices, a key driver for Norway's economy. November futures for WTI crude fell 4.17% to trade at $92.07 per barrel, while Brent crude futures for the same month dropped 3.70% to $100.03 per barrel.
In currency markets, the Norwegian krone weakened against major currencies. The EUR/NOK pair rose 0.14% to 10.82, while the USD/NOK gained 0.23% to 9.43, reflecting pressure on the oil-sensitive currency amid a stronger U.S. Dollar Index.
Read next
More on Stocks
AI Leaders Anthropic and OpenAI Take Divergent IPO Paths Amid Regulatory Debate
Leading AI firms Anthropic and OpenAI are navigating the complex landscape of potential government regulation as they plan their public market debuts, with each adopting a distinct strategy to manage investor perceptions and market timing.
Grail Shares Surge 35% as FDA Staff Finds No Major Issues With Galleri Cancer Test
Shares of Grail soared after U.S. Food and Drug Administration staff reviewers found no major safety or accuracy concerns with its Galleri multi-cancer blood test ahead of a key advisory panel meeting.
AMD Briefly Hits $1 Trillion Valuation on AI Optimism
The chipmaker became the fourth in the U.S. to reach the milestone as its stock surged, fueled by investor confidence in its strategy to compete in the artificial intelligence computing market.
GAC Unveils Plan to Launch 12 Electric Models in France by 2030
The Chinese automaker announced an aggressive European expansion, aiming to introduce 12 electric and hybrid vehicles and establish a 200-strong dealership network in France over the next six years.